ResMed, Inc. (RMD)
ResMed Market Cap: 37.60B for Jan. 16, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Boston Scientific Corp. | 130.56B |
| Abbott Laboratories | 211.73B |
| Stryker Corp. | 139.12B |
| West Pharmaceutical Services, Inc. | 18.69B |
| Insulet Corp. | 20.24B |
Market Cap Related Metrics
| PE Ratio | 26.36 |
| PS Ratio | 7.210 |
| PEG Ratio | 0.8925 |
| Price to Book Value | 6.142 |
| Price to Free Cash Flow | 21.58 |
| Price | 257.58 |
| Earnings Yield | 3.79% |
| PEGY Ratio | 0.8668 |
| Operating PE Ratio | 21.51 |
| Normalized PE Ratio | 26.26 |